|
Volumn 61, Issue 2, 2001, Pages 179-189
|
Enzyme-catalyzed therapeutic agent (ECTA) design: Activation of the antitumor ECTA compound NB1011 by thymidylate synthase
|
Author keywords
Cancer; Chemotherapy; Drug resistance; Nucleoside analog; Phosphoramidate; Thymidylate synthase
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANTIVIRUS AGENT;
FLOXURIDINE PHOSPHATE;
FLUOROPYRIMIDINE;
FLUOROURACIL;
HOMOCYSTEINE;
MERCAPTOETHANOL;
NB 1011;
PHOSPHORAMIDIC ACID;
RALTITREXED;
THYMIDYLATE SYNTHASE;
THYMIDYLATE SYNTHASE INHIBITOR;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER CHEMOTHERAPY;
CARCINOMA CELL;
CELL PROLIFERATION;
COLORECTAL CARCINOMA;
CONTROLLED STUDY;
CYTOTOXICITY;
DRUG ACTIVATION;
DRUG DELIVERY SYSTEM;
DRUG SENSITIVITY;
DRUG SYNTHESIS;
HUMAN;
HUMAN CELL;
IN VIVO STUDY;
MOUSE;
NONHUMAN;
NUDE MOUSE;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
REACTION ANALYSIS;
XENOGRAFT;
ANIMALS;
ANTINEOPLASTIC AGENTS;
BROMODEOXYURIDINE;
DEOXYURACIL NUCLEOTIDES;
DISEASE MODELS, ANIMAL;
DRUG DESIGN;
DRUG SCREENING ASSAYS, ANTITUMOR;
HUMANS;
MICE;
MICE, NUDE;
PRODRUGS;
THYMIDYLATE SYNTHASE;
TUMOR CELLS, CULTURED;
XENOGRAFT MODEL ANTITUMOR ASSAYS;
|
EID: 0035863169
PISSN: 00062952
EISSN: None
Source Type: Journal
DOI: 10.1016/S0006-2952(00)00542-6 Document Type: Article |
Times cited : (35)
|
References (24)
|